Mosaic Therapeutics Appoints Thomas Fuchs As CEO
20 Oct 2025 //
BUSINESS WIRE
Mosaic licenses 2 clinical stage tumor drugs from Otsuka`s Astex
24 Apr 2025 //
FIERCE BIOTECH
Mosaic Closes $28m Series A Funding and Appoints Brian Gladsden as CEO
04 Apr 2023 //
BUSINESSWIRE

Market Place
Sourcing Support